Breaking News
Sort by:
Top Post
Almirall Appoints Mercedes Diz as VP, Corporate Strategy
Almirall, a global biopharmaceutical company focused on skin health, today announced that Mercedes Diz will […]
The OSE Immunotherapeutics Board of Directors Proposes the Appointment of Eric Leire, MD, as New Independent Director
OSE Immunotherapeutics, a biotech company dedicated to developing first-in-class assets in immuno-oncology and immuno-inflammation, today […]
Cartography Biosciences Expands Scientific Advisory Board with Leading Antibody and Bi-specific Experts
Cartography Biosciences, an immuno-oncology company creating biologic therapies against novel targets guided by the first-ever […]
Juha Punnonen, M.D., Ph.D. Joins Hinge Bio as Chief Development Officer
Hinge Bio, a privately-held biotechnology company, today announced that Juha Punnonen, M.D., Ph.D. has joined […]
Acurex Biosciences Appoints Esteemed Biopharmaceutical Leader Dr. Robert Booth to its Board of Directors
Acurex Biosciences, a biopharmaceutical company with a mission to stop neurodegeneration before it begins, announces […]
Topas Therapeutics Initiates Phase 2a Clinical Trial for TPM502 in Celiac Disease; Appoints Chief Business Officer and Chief Operating Officer
Topas Therapeutics, a clinical-stage biotech company developing novel antigen-specific immune tolerance therapies to treat autoimmune […]
Woebot Health Names Matt Borowiecki Chief Financial Officer
Woebot Health, a mental health ally for people and businesses, today announced that it has […]
HuidaGene Therapeutics Appoints Alvin Luk as Chief Executive Officer
HuidaGene Therapeutics, a clinical-stage genome-editing company, today announced the appointment of gene therapy industry veteran, […]
Bob Battista Joins Platform Life Sciences as EVP, Chief Strategy & Commercial Officer
Platform Life Sciences, a global impact research organization, has announced the appointment of Bob Battista as […]
Obsidian Therapeutics Announces Dr. Madan Jagasia as Chief Executive Officer and Other Leadership Appointments
Obsidian Therapeutics, a clinical-stage biotechnology company pioneering engineered cell and gene therapies, today announced the […]
Life Biosciences Expands Team with the Appointment of Ming Yang, Ph.D., as SVP of Research and Development
Life Biosciences (“Life Bio”), a biotechnology company advancing innovative cellular rejuvenation platforms to reverse diseases […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more